Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_assertion type Assertion NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_head.
- NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_assertion description "[We analyzed TMPRSS2-ERG gene rearrangement status by fluorescence in situ hybridization in 521 cases of clinically localized surgically treated prostate cancer with 95 months of median follow-up and also in 40 unmatched metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_provenance.
- NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_assertion evidence source_evidence_literature NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_provenance.
- NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_assertion SIO_000772 19190343 NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_provenance.
- NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_assertion wasDerivedFrom befree-20150227 NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_provenance.
- NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_assertion wasGeneratedBy ECO_0000203 NP383343.RAQSXgWvH-Zr5hx-oVvrgbcIafpndGUJRw4uowy3ZMCcA130_provenance.